You are here

News

April

James Baumgartner, MD
Apr 2014   During the last 25 years, stem cells derived from umbilical cord blood have been used in more than 30,000 transplants performed worldwide for the treatment of over 80 diseases and disorders in both adults and children. The evolution of stem cell therapies has paved the way for further research being conducted through FDA-regulated clinical trials to uncover their potential in regenerative medicine applications.
Hearing Loss Association of America
Apr 2014   The Hearing Loss Association of America® (HLAA) is the nation's foremost membership and advocacy organization for people with hearing loss. The mission of HLAA is to open the world of communication for people with hearing loss through information, education, support and advocacy.
Roberto Waddington
Apr 2014   This simple question has been lingering unanswered over private cord blood banks around the world for years. Despite compelling data on the growing therapeutic use of cord blood, both in terms of treatable diseases and numbers of therapies, often medical doctors are still reluctant to embrace the value of family cord blood banking. In many countries, such as Brazil, this sector is still plagued with mostly unfounded controversy, such as the "public versus private" banking debate.